SCHEMBL31661287

SCHEMBL31661287

O=C(NC(=S)Nc1ccc(Cl)cn1)c1ccccc1

nearest known ligand 0.75

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.75
NPC1 O15118 7/20 0.75
KMT2A Q03164 5/20 0.67
ALDH1A1 P00352 4/20 0.67
MEN1 O00255 4/20 0.67
NPSR1 Q6W5P4 3/20 0.67
MAPT P10636 2/20 0.67
LMNA P02545 1/20 0.67
HTT P42858 1/20 0.67
PKM P14618 2/20 0.66
L3MBTL1 Q9Y468 2/20 0.65
SMN1; SMN2 Q16637 1/20 0.65
EPHX1 P07099 2/20 0.63
CASP3 P42574 1/20 0.59
SENP8 Q96LD8 1/20 0.59
SENP7 Q9BQF6 1/20 0.59
SENP6 Q9GZR1 1/20 0.59
THRB P10828 1/20 0.57
HPGD P15428 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7069217 0.85 KMT2A (0.79) RAB9ANPC1KMT2AALDH1A1MEN1
SCHEMBL16295141 0.84 MAPT (0.69) RAB9ANPC1KMT2AALDH1A1MEN1
SCHEMBL26854287 0.83 RAB9A (0.66) RAB9ANPC1KMT2AALDH1A1MEN1
SCHEMBL31398683 0.80 NPC1 (0.61) RAB9ANPC1KMT2AALDH1A1MEN1
SCHEMBL2682648 0.80 RAB9A (1.00) RAB9ANPC1KMT2AALDH1A1MEN1
SCHEMBL558304 0.78 NPC1 (0.62) RAB9ANPC1ALDH1A1NPSR1LMNA
SCHEMBL16670942 0.78 RAB9A (0.77) RAB9ANPC1KMT2AALDH1A1MEN1
SCHEMBL19329247 0.76 EPHX1 (0.63) RAB9ANPC1KMT2AALDH1A1MEN1
SCHEMBL2871030 0.76 SMN1; SMN2 (0.57) RAB9ANPC1KMT2AALDH1A1MEN1
SCHEMBL2832098 0.76 NPC1 (0.72) RAB9ANPC1KMT2AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151517-A1 THIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS ASSOCIATED WITH MISSFOLDING OF ALPHA-SYNUCLEIN PROTEIN WAVEBREAK THERAPEUTICS LIMITED (US) 2025-07-17 WO disclosed